beta Amyloid anticorps (C-Term)

N° du produit ABIN614817

Cet anticorps anti-beta Amyloid Monoclonal Souris (Clone CV9 7B10) (ABIN614817) détecte spécifiquement beta Amyloid dans EIA et ELISA (Detection). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour beta Amyloid anticorps (C-Term) (ABIN614817)

Antigène: beta Amyloid (Abeta) (Amyloid beta (Abeta))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp beta Amyloid est non-conjugé

Application: Enzyme Immunoassay (EIA), ELISA (Detection)

Clone: CV9 7B10

Détail du produit anti-beta Amyloid anticorps

Épitope: C-Term

Séquence: GLMVGGVV

Specificité: This antibody recognizes the C-terminal peptide of beta amyloid peptide 40, and full length beta amyloid peptide 40.

Réactivité croisée (Details): Species reactivity (tested):Human.

Purification: Protein G affinity chromatography

Immunogène: C-terminal amino acid sequence of human beta amyloid peptide 40, conjugated with KLH

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Reconstitution: Restore with Double distillated water is recommended to adjust the final concentration to 1.0 mg/mL.

Buffer: 0.01 M PBS pH 7.2

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: -20 °C

Stockage commentaire: Store (in aliquots) at -20 °C.

Détails sur beta Amyloid

Antigène: beta Amyloid (Abeta) (Amyloid beta (Abeta))

Autre désignation: Amyloid beta

Sujet: Aβ40, Aβ42 and Aβ43 are different only at the few C-end amino acids. While the C-end amino acids showed no speciesspecificity in mammalians, the Nterminal amino acid sequences have minor discrepancies between difference species. Amyloid beta peptides Aβ42 and Aβ40 have been investigated extensively for predicating Alzheimer's disease. A recent study on A Aβ43 in brain showed that Aβ43 is more fibrillogenic than the other amyloid beta peptides and may be useful as a biomarker or therapeutic target for Alzheimer's disease. Antibody to N-terminal sequence can bind to all the three amyloid beta peptides.

ID gène: 351

Pathways: Inflammasome